Mohammad Mahdi Barati Jozan (Mohammad Mashreghi)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Walled Carbon Nanotubes

Top Venues

Journal of functional biomaterials

Biotechnology progress

Journal of drug targeting

BMC public health

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Mohammad Mahdi Barati Jozan, Mohsen Qayoomian, Mohammad Reza Hashemzadeh, Bernabé Nuñez-Estevez, Mohammad Ehsan Taghavizadeh Yazdi
Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering. Journal of functional biomaterials 14 (1) (2023)
Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Mohammad Mahdi Barati Jozan, Mohsen Qayoomian, Mohammad Reza Hashemzadeh, Bernabé Nuñez-Estevez, Mohammad Ehsan Taghavizadeh Yazdi
Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering. Journal of functional biomaterials 14 (1) (2023)
Mohammad Mahdi Barati Jozan, Babak Daneshvar Ghorbani, Md Saifuddin Khalid, Aynaz Lotfata, Hamed Tabesh
Impact assessment of e-trainings in occupational safety and health: a literature review. BMC public health 23 (1) (2023)
Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Mohammad Mahdi Barati Jozan, Mohsen Qayoomian, Mohammad Reza Hashemzadeh, Bernabé Nuñez-Estevez, Mohammad Ehsan Taghavizadeh Yazdi
Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering. Journal of functional biomaterials 14 (1) (2023)
Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Mohammad Mahdi Barati Jozan, Mohsen Qayoomian, Mohammad Reza Hashemzadeh, Bernabé Nuñez-Estevez, Mohammad Ehsan Taghavizadeh Yazdi
Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering. Journal of functional biomaterials 14 (1) (2023)
Seyed Mousa Mousavi-Kouhi, Abdollah Beyk-Khormizi, Mohammad Sadegh Amiri, Mohammad Mahdi Barati Jozan, Alireza Hashemzadeh, Vahideh Mohammadzadeh, Fariba Alavi, Javad Mottaghipisheh, Mohammad Reza Sarafraz Ardakani, Mohammad Ehsan Taghavizadeh Yazdi
Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa : Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines. Journal of functional biomaterials 14 (7) (2023)
Atefeh Biabangard, Ahmad Asoodeh, Mahmoud Reza Jaafari, Mohammad Mahdi Barati Jozan
Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study. Expert opinion on drug delivery (2022)
Mohammad Mahdi Barati Jozan, Mahdi Faal Maleki, Maryam Karimi, Fatemeh Kalalinia, Ali Badiee, Mahmoud Reza Jaafari
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide. Journal of drug targeting 29 (6) (2021)
Mehdi Barati, Farshad Mirzavi, Amin Reza Nikpoor, Mojtaba Sankian, Hasan Namdar Ahmadabad, Anvar Soleimani, Mohammad Mahdi Barati Jozan, Jalil Tavakol Afshar, Mojgan Mohammadi, Mahmoud Reza Jaafari
Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes. Cancer gene therapy (2021)
Mohammad Mahdi Barati Jozan, Parvin Zamani, Maryam Karimi, Amin Mehrabian, Mahdieh Arabsalmani, Javad Zarqi, Seyedeh Alia Moosavian, Mahmoud Reza Jaafari
Anti-epithelial cell adhesion molecule RNA aptamer-conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model. Biotechnology progress 37 (3) (2021)